M

Moderna

Develops mRNA-based medicines for health

Associate Director - HEOR

Biology & BiotechConfirmed live in the last 24 hours
Full-timeToronto, ON, Canada

About the Job

Requirements

  • A Ph.D., Sc.D., or Dr.P.H., or completion of all Ph.D., Sc.D., or Dr.P.H. requirements with the degree expected to be conferred by 2029; alternatively, an advanced degree in life sciences or a clinical degree (for example, medicine, pharmacy, or nursing) and a master’s degree in a related discipline.
  • Demonstrated HEOR experience supporting vaccines in the Canadian setting, including evidence generation, real-world evidence, health economics analyses, reimbursement, or public health decision-making.
  • At least 5 years of progressive HEOR experience within the pharmaceutical, biotechnology, vaccines, or healthcare industry.
  • At least 2 years of work authorization is required for this role.

Responsibilities

  • Lead development and execution of local HEOR strategies, evidence generation activities, and key deliverables, such as value dossiers, to demonstrate product value and support reimbursement, market access, vaccine recommendations, tendering and contracting, and institutional customer engagement.
  • Communicate HEOR evidence as part of NITAG/HTA submissions, vaccine recommendation processes, and pricing negotiations.
  • Represent HEOR on Medical, Market Access and Pricing, and Commercial cross-functional teams as a subject matter expert on payer product value proposition and HEOR scientific evidence, and align HEOR initiatives with business needs.
  • Represent HEOR in early scientific engagement, benefit assessment, and vaccine recommendation processes.
  • Drive local and contribute to global HEOR program and study design execution.
  • Identify and communicate local HEOR evidence requirements and gaps.
  • Partner with cross-functional and global teams to develop communication materials for HEOR data, including value dossiers and other payer-relevant content.
  • Develop and deliver data and data visualizations for omnichannel engagement of institutional customers.
  • Manage external research vendors and consultants to deliver results.
  • Lead localization and de novo development of HEOR studies and economic models.
  • Support real-world evidence and economic modelling strategies for benefit assessments, vaccine recommendations, pricing, and patient access at country level.
  • Provide local HEOR input into strategic planning processes and decision gates.
  • Develop HEOR content and tools to support payer and stakeholder engagement.
  • Lead and execute HEOR publication plans.

Desired Qualifications

  • At least 7 years of experience within the biopharmaceutical, vaccines, or healthcare industry.
  • Strong understanding of the Canadian healthcare system, reimbursement pathways, public health decision-making, and NITAG/HTA processes, including NACI.
  • Experience generating payer- and public health-relevant evidence, including real-world evidence and economic models.
  • Experience developing value dossiers, tender submissions, and materials supporting vaccine recommendations and reimbursement decisions.
  • Strong knowledge of HEOR methodologies, evidence-based medicine, patient-reported outcomes, and data analytics.
  • Ability to work cross-functionally and influence internal and external stakeholders without direct authority.
  • Written and verbal communication skills, including communicating complex data and insights through visualization and storytelling.
  • Experience managing external vendors, consultants, and research partners.
  • Ability to manage multiple priorities in a fast-paced, evolving environment with attention to detail and execution.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs